BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

763 related articles for article (PubMed ID: 28718405)

  • 1. RNA-Binding Proteins in Cancer: Old Players and New Actors.
    Pereira B; Billaud M; Almeida R
    Trends Cancer; 2017 Jul; 3(7):506-528. PubMed ID: 28718405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dissecting the expression relationships between RNA-binding proteins and their cognate targets in eukaryotic post-transcriptional regulatory networks.
    Nishtala S; Neelamraju Y; Janga SC
    Sci Rep; 2016 May; 6():25711. PubMed ID: 27161996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TF-RBP-AS Triplet Analysis Reveals the Mechanisms of Aberrant Alternative Splicing Events in Kidney Cancer: Implications for Their Possible Clinical Use as Prognostic and Therapeutic Biomarkers.
    He M; Hu F
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transposable elements modulate human RNA abundance and splicing via specific RNA-protein interactions.
    Kelley DR; Hendrickson DG; Tenen D; Rinn JL
    Genome Biol; 2014 Dec; 15(12):537. PubMed ID: 25572935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emerging Multi-cancer Regulatory Role of ESRP1: Orchestration of Alternative Splicing to Control EMT.
    Vadlamudi Y; Dey DK; Kang SC
    Curr Cancer Drug Targets; 2020; 20(9):654-665. PubMed ID: 32564755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging roles of RNA and RNA-binding protein network in cancer cells.
    Kim MY; Hur J; Jeong S
    BMB Rep; 2009 Mar; 42(3):125-30. PubMed ID: 19335997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multidimensional crosstalk between RNA-binding proteins and noncoding RNAs in cancer biology.
    Li L; Miao H; Chang Y; Yao H; Zhao Y; Wu F; Song X
    Semin Cancer Biol; 2021 Oct; 75():84-96. PubMed ID: 33722631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In cancer, A-to-I RNA editing can be the driver, the passenger, or the mechanic.
    Ganem NS; Ben-Asher N; Lamm AT
    Drug Resist Updat; 2017 May; 32():16-22. PubMed ID: 29145975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. POSTAR: a platform for exploring post-transcriptional regulation coordinated by RNA-binding proteins.
    Hu B; Yang YT; Huang Y; Zhu Y; Lu ZJ
    Nucleic Acids Res; 2017 Jan; 45(D1):D104-D114. PubMed ID: 28053162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutational landscape of RNA-binding proteins in human cancers.
    Neelamraju Y; Gonzalez-Perez A; Bhat-Nakshatri P; Nakshatri H; Janga SC
    RNA Biol; 2018 Jan; 15(1):115-129. PubMed ID: 29023197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Matrix-screening reveals a vast potential for direct protein-protein interactions among RNA binding proteins.
    Lang B; Yang JS; Garriga-Canut M; Speroni S; Aschern M; Gili M; Hoffmann T; Tartaglia GG; Maurer SP
    Nucleic Acids Res; 2021 Jul; 49(12):6702-6721. PubMed ID: 34133714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of immunomodulatory RNA-binding proteins in tumors.
    Friedrich M; Lazaridou MF; Rahn J; Vaxevanis C; Heimer N; Jasinski-Bergner S; Seliger B
    Methods Enzymol; 2020; 636():339-350. PubMed ID: 32178825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of the RNA-binding protein La in cancer pathobiology.
    Sommer G; Heise T
    RNA Biol; 2021 Feb; 18(2):218-236. PubMed ID: 32687431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RNA-binding protein-mediated post-transcriptional controls of gene expression: integration of molecular mechanisms at the 3' end of mRNAs?
    Vindry C; Vo Ngoc L; Kruys V; Gueydan C
    Biochem Pharmacol; 2014 Jun; 89(4):431-40. PubMed ID: 24735612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of post-transcriptional regulation during cancer progression using a donor-derived isogenic model of tumorigenesis.
    Bisogno LS; Keene JD
    Methods; 2017 Aug; 126():193-200. PubMed ID: 28529064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cooperation and competition by RNA-binding proteins in cancer.
    Nag S; Goswami B; Das Mandal S; Ray PS
    Semin Cancer Biol; 2022 Nov; 86(Pt 3):286-297. PubMed ID: 35248729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RNA-binding proteins in regulating mRNA stability and translation: roles and mechanisms in cancer.
    Li W; Deng X; Chen J
    Semin Cancer Biol; 2022 Nov; 86(Pt 2):664-677. PubMed ID: 35381329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA damage: RNA-binding proteins protect from near and far.
    Dutertre M; Lambert S; Carreira A; Amor-Guéret M; Vagner S
    Trends Biochem Sci; 2014 Mar; 39(3):141-9. PubMed ID: 24534650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New sequencing methodologies reveal interplay between multiple RNA-binding proteins and their RNAs.
    Melamed S
    Curr Genet; 2020 Aug; 66(4):713-717. PubMed ID: 32193580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RNA-binding proteins, multifaceted translational regulators in cancer.
    Wurth L; Gebauer F
    Biochim Biophys Acta; 2015 Jul; 1849(7):881-6. PubMed ID: 25316157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.